SB1880112th GA (Historical)Introduced

Amends TCA Title 33; Title 53; Title 63 and Title 68.

This bill prohibits a licensing board or disciplinary subcommittee from acting against a physician's license based solely on the physician's recommendations to a patient regarding treatment for COVID-19, so long as the physician exercised independent medical judgment and believes that the medical treatment is in the best interest of the patient. This bill also prohibits pharmacies from blocking or attempting to block a patient's access to a drug, biological product, or device solely prescribed as a treatment for COVID-19 on the basis that the United States FDA has not approved the drug, biological product, or device to treat COVID-19.

What moved, what's on next week's agenda, new filings — every Monday, from the public record, free.

No account. Unsubscribe in one click.

Overview

This bill prohibits a licensing board or disciplinary subcommittee from acting against a physician's license based solely on the physician's recommendations to a patient regarding treatment for COVID-19, so long as the physician exercised independent medical judgment and believes that the medical treatment is in the best interest of the patient. This bill also prohibits pharmacies from blocking or attempting to block a patient's access to a drug, biological product, or device solely prescribed as a treatment for COVID-19 on the basis that the United States FDA has not approved the drug, biological product, or device to treat COVID-19.

Track Tennessee Legislation Like a Pro

Join hundreds of professionals using LegisGo to stay ahead of legislative changes.

Instant Alerts

Get notified when bills you track move through the legislature

AI Summaries

Understand complex legislation in seconds with AI-powered analysis

Full Access

All 132 legislators, committee schedules, and voting records

Sponsor

Unknown

Details
Session

112th General Assembly

Introduced

January 24, 2022

Subjects
2170386536703660

Want to track this bill? Get instant alerts and AI-powered insights.